Efficacy of early anti-inflammatory treatment with high doses of intravenous anakinra with or without glucocorticoids in patients with severe COVID-19 pneumonia

IL-1 plays a pivotal role in the inflammatory response during cytokine storm syndromes.

Read the full article here

Related Articles